Epidemiological and Clinical Profile of Deaths due to COVID-19 among Hospitalized Patients in Sidama Region, Ethiopia
Table 4. Summary of ICU admission status anddisease severity among COVID-19 related deaths
| Variables | Severity status | Intensive care unit admission | ||||
| Yes | No | p-value | Yes | No | p-value | |
| Age group |
|
|
|
|
|
|
| 18-39 | 8(24.2%) | 25(75.8%) | 0.73 | 19(57.6%) | 14(42.4%) | 0.457 |
| 40-60 | 15(22.4%) | 52(77.6%) |
| 47(70.1%) | 20(29.9%) |
|
| ≥61 | 24(27.9%) | 62(72.1%) |
| 56(65.1%) | 30(34.9%) |
|
| Sex |
|
|
|
|
|
|
| Male | 34(25.2%) | 101(74.8%) | 0.966 | 87(64.4%) | 48(35.6%) | 0.592 |
| Female | 13(25.5%) | 38(74.5%) |
| 35(68.6%) | 16(31.4%) |
|
| Comorbidity |
|
|
|
|
|
|
| Yes | 36(30%) | 84(70%) | 0.045 | 85(70.8%) | 35(29.2%) | 0.042 |
| No | 11(16.7%) | 55(83.3%) |
| 37(56.1%) | 29(43.9%) |
|
| Comorbidity number |
|
|
|
|
|
|
| One | 29(37.7%) | 48(62.3%) | 0.014 | 54(70.1%) | 23(29.9%) | 0.821 |
| Two or more | 7(16.3%) | 36(83.7%) |
| 31(72.1%) | 12(27.9%) |
|
| Comorbidity type |
|
|
|
|
|
|
| Diabetes | 15(25%) | 45(75%) | 0.232 | 47(78.1%) | 13(21.7%) | 0.07 |
| HTN | 11(23.4%) | 36(76.6%) | 0.206 | 34(72.3%) | 13(27.7%) | 0.771 |
| HIV/AIDS | 2(28.6%) | 5(71.2%) | 1.00 f | 3(42.9%) | 4(57.1%) | 0.19 f |
| Cancer | 1(20%) | 4(80%) | 1.00 f | 1(20%) | 4(80%) | 0.25 f |
| Asthma | 1(12.5%) | 7(87.5%) | 0.433 f | 7(87.5%) | 1(12.5%) | 0.43f |
| Renal disease | 2(14.3%) | 12(85.7%) | 0.225 | 9(64.3%) | 5(35.7%) | 0.54f |
| Stroke | 1(25%) | 3(75%) | 1.00 f | 3(75%) | 1(25%) | 1.0f |
| Cardiac disease | 4(30.8%) | 9(69.2%) | 1.00 f | 9(69.2%) | 4(30.8%) | 1.0f |
f; fisher exact test